Skip to main content
Signal8

Syros Pharmaceuticals, Inc. (SYRS)

Syros Pharmaceuticals, Inc. operates as a biopharmaceutical firm primarily focused on discovering and developing novel therapeutic solutions for various cancers and monogenic (single-gene) diseases. A key strategic aim for the company involves cultivating a robust pipeline of medicines that modulate gene expression. Its leading investigational drug candidates include: Tamibarotene: A selective retinoic acid receptor alpha agonist, currently undergoing Phase III clinical trials for a genetically defined subset of patients with myelodysplastic syndrome, and in Phase II trials for individuals suffering from acute myeloid leukemia. SY-2101: An innovative oral formulation of arsenic trioxide, intended for the treatment of acute promyelocytic leukemia. SY-5609: A cyclin-dependent kinase 7 inhibitor, which is being assessed in a Phase I clinical study involving patients with specific advanced solid tumors. Syros maintains several strategic alliances, notably a research collaboration and option agreement with Incyte Corporation centered on identifying therapeutic targets for myeloproliferative neoplasms. Furthermore, the company has a licensing arrangement with TMRC Co. Ltd. pertaining to the development and commercialization of tamibarotene. Initially incorporated in 2011 as LS22, Inc., the company officially adopted the name Syros Pharmaceuticals, Inc. in August 2012. Its corporate headquarters are located in Cambridge, Massachusetts.

Sector: Biotechnology

Industry: Biotechnology

Syros Pharmaceuticals, Inc. logo

Syros Pharmaceuticals, Inc.

OTC:SYRSHealthcare
$0.0001
CLOSED
Mkt Cap$3K
EV-
Float26.83M
O/S26.83M
VOL2K sh
$ Vol$0
RVOL0.35×
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
Syros Pharmaceuticals, Inc. logoOTC:SYRSClosed$0.0001
Financials Summary
Revenue$9.94M
Net Income-$164.57M
Total Assets$168.17M
Free Cash Flow-$109.98M
Debt & Equity
Debt 79%
Equity 21%
Total Debt$62.08M
Total Equity$16.66M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:10Reverse split
    Sep 19, 202210 shares → 1
Balance Sheet Details
Assets$168.17M
Liabilities$151.51M
Accounts Receivable$0
Accounts Payable$11.54M
Inventory$0
PP&E (Net)$19.48M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue$9.94M$14.88M$23.49M$15.09M$1.98M$2.05M$1.1M$317K$317K$0$0
YoY Growth-33.2%-36.6%55.6%661.5%-3.3%86.2%247.3%0.0%---
Cost of Revenue$2.25M$2.97M$0$0$0$0$1.53M$0$602K$0$0
Gross Profit$7.68M$11.91M$23.49M$15.09M$1.98M$2.05M-$426K$317K-$285K$0$0
Gross Margin77.3%80.1%100.0%100.0%100.0%100.0%-38.7%100.0%-89.9%--
Research and Development$108.15M$111.94M$99.87M$76.06M$58.24M$50.18M$41.9M$37.82M$24.41M$10.92M$6.27M
Selling, General, and Administrative$28.28M$29.3M$23.04M$21.32M$21.48M$16.16M$13.89M$10.46M$5.73M$2.51M$2.37M
Other-$105.66M-$102.43M$0$0$0$0$676K$220K$2K$4K$0
Total Operating Expenses$30.77M$38.81M$122.91M$97.39M$79.72M$66.35M$55.79M$48.28M$30.14M$13.44M$8.66M
Operating Income (EBIT)-$128.99M-$135.87M-$99.42M-$82.3M-$77.74M-$64.3M-$54.69M-$47.96M-$29.82M-$13.44M-$8.63M
Operating Margin-1298.2%-913.1%-423.3%-545.3%-3922.4%-3136.4%-4966.9%-15130.3%-9406.9%--
Interest Expense$5.13M$4.13M$3.91M$1.79M$0$1K$0$0$0$0$0
Interest Income$6.82M$2.13M$87K$426K$2.3M$2.02M$0$0$0$0$0
Other Income (Expense)-$35.59M$41.22M$12.86M-$1.74M$2.3M$2.02M$676K$220K$2K$4K-$32K
Income Before Tax (EBT)-$164.57M-$94.65M-$86.56M-$84.04M-$75.44M-$62.28M-$54.01M-$47.74M-$29.82M-$13.43M-$8.66M
Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0
Net Income-$164.57M-$94.65M-$86.56M-$84.04M-$75.44M-$62.28M-$54.01M-$47.74M-$29.82M-$13.43M-$9.26M
Net Income Margin-1656.3%-636.1%-368.5%-556.8%-3806.2%-3038.0%-4905.5%-15060.9%-9406.3%--
Supplementary Data
EPS-5.81-7.49-13.84-18.25-18.76-19.07-21.26-37.60-120.45-54.25-84.47
Diluted EPS-5.81-7.49-13.84-18.25-18.76-19.07-21.26-37.60-120.45-54.25-84.47
Weighted Average OS28.33M12.63M6.25M4.61M4.02M3.27M2.54M1.27M247,557247,557109,619
EBITDA-$157.19M-$87.55M-$79.63M-$79.21M-$72.72M-$60.67M-$53.16M-$46.69M-$29.22M-$13.18M-$8.46M
EBITDA Margin-1582.1%-588.4%-339.0%-524.8%-3668.8%-2959.8%-4828.2%-14728.7%-9217.0%--
Balance Sheet
PeriodFY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Assets
Current Assets
Cash and Cash Equivalents$139.53M$167.47M$92.3M$173.98M$41.44M$49.89M$32.2M$58.59M$35.91M$60.39M$3.8M
Short-Term Investments$0$34.84M$38.07M$0$49.98M$49.79M$39.84M$25M$0$0$0
Cash and Short-Term Investments$139.53M$202.3M$130.37M$173.98M$91.42M$99.68M$72.05M$83.59M$35.91M$60.39M$3.8M
Accounts Receivable$0$1.69M$2.98M$2.33M$20.16M$0$0$867K$0$0$0
Inventory$0$0$0$0$290K$0$0$0$0$0$0
Other Current Assets$5.45M$7.39M$0$0$0$638K$193K$1.05M$0$0$0
Total Current Assets$144.98M$211.39M$136.59M$178.56M$114.51M$101.73M$73.16M$85.51M$36.45M$60.54M$3.91M
Long-Term Assets
Property, Plant & Equipment Net$19.48M$24.66M$27.29M$29.64M$31.89M$3.86M$3.94M$4.85M$4.8M$881K$938K
Goodwill$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$2.12M$3.09M$13.04M$3.09M$3.09M$290K$290K$483K$483K$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$1.59M$5.35M$6.03M$1.97M$490K$881K$1.1M$482K$1.9M$70K$70K
Total Long-Term Assets$23.19M$33.09M$46.35M$34.69M$35.47M$5.03M$5.33M$5.82M$7.18M$951K$1.01M
Other Assets$0$0$0$0$0$0$0$0$0$0$0
Total Assets$168.17M$244.49M$182.94M$213.25M$149.98M$106.77M$78.49M$91.32M$43.63M$61.49M$4.92M
Liabilities
Current Liabilities
Accounts Payable$11.54M$6.41M$3.69M$3.6M$5.85M$3.31M$2.28M$2.42M$5.04M$928K$594K
Short-Term Debt$6.67M$0$0$0$0$0$0$0$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$4.33M$10.18M$12.21M$5.74M$1.93M$355K$550K$0$0$0
Other Current Liabilities$6.99M$9.44M$9.28M$5.71M$6.47M$11.3M$7.23M$4.52M$284K$37K$36K
Total Current Liabilities$36.68M$30.78M$31.51M$28.62M$23.52M$19.53M$12.41M$9.57M$7.96M$1.25M$910K
Long-Term Liabilities
Long-Term Debt$34.56M$40.65M$40.26M$39.55M$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$9.88M$22.64M$8.28M$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0-$22K$0$0$0$0$0
Other Long-Term Liabilities$61.75M$24.47M$3.03M$19.71M$0$353K$745K$1.1M$1.42M$1K$0
Total Long-Term Liabilities$114.83M$85.97M$66.21M$94.07M$47.28M$8.65M$751K$1.15M$1.63M$1K$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$151.51M$116.75M$97.72M$122.7M$70.79M$28.18M$13.16M$10.72M$9.58M$1.25M$910K
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$82.01M$82.01M$13.27M
Common Stock$26K$20K$61K$56K$43K$34K$26K$23K$2K$1K$5K
Retained Earnings-$722.81M-$558.23M-$463.58M-$377.02M-$292.98M-$217.54M-$155.27M-$101.26M-$53.51M-$23.7M-$10.26M
Comprehensive Income & Other$0$102K-$79K$0$24K-$3K-$42K-$9K-$931K-$428K$0
Other Stockholders' Equity$739.44M$685.95M$548.74M$467.52M$372.12M$296.1M$220.56M$181.84M$87.56M$83.94M$14.23M
Total Equity$16.66M$127.74M$85.22M$90.55M$79.18M$78.59M$65.32M$80.6M$34.05M$60.24M$3.97M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$168.17M$244.49M$182.94M$213.25M$149.98M$106.77M$78.49M$91.32M$43.63M$61.49M$4.88M
Supplementary Data
Total Debt$62.08M$63.57M$65.19M$66.21M$25.92M$31K$53K$221K$339K$0$0
Net Debt-$77.45M-$103.9M-$27.11M-$107.77M-$15.52M-$49.85M-$32.15M-$58.37M-$35.57M-$60.39M-$3.8M
Cash Flow Statement
PeriodFY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Operating Activities
Net Income-$164.57M-$94.65M-$86.56M-$84.04M-$75.44M-$62.28M-$54.01M-$47.74M-$29.82M-$13.43M-$8.66M
Depreciation & Amortization$2.25M$2.97M$3.02M$3.04M$2.72M$1.6M$1.53M$1.27M$602K$258K$170K
Deferred Income Tax$0$0-$16.46M$326K-$1.13M$0$0$0$0$0$0
Stock-Based Compensation$10.43M$11.41M$10.35M$10.94M$9.84M$6.61M$4.42M$4.23M$3.23M$937K$821K
Changes in Working Capital:
  Accounts Receivable$1.69M$1.28M$7K$19.99M-$20.16M$0$867K-$317K$0$0$0
  Inventory$0-$1.28M$1.98M-$2.53M-$4.36M$0$3.3M$2.69M$0$0$0
  Accounts Payable$5.13M$2.77M$48K-$1.06M$1.49M$888K$141K-$404K$2.02M$334K$0
  Other Working Capital-$1.77M-$8.28M-$12.64M-$6.35M$19.54M$13.5M-$870K-$284K$914K-$67K$86K
Total Working Capital Change$5.05M-$5.52M-$10.6M$10.05M-$3.48M$14.39M$3.44M$1.69M$2.94M$267K$86K
Other Non-Cash Items$37.13M-$37.27M$706K$2.32M$7.24M-$642K-$102K$10K$17K$334K$394K
Net Cash from Operating-$109.71M-$123.06M-$99.54M-$57.36M-$60.25M-$40.31M-$44.73M-$40.54M-$23.03M-$11.97M-$7.19M
Investing Activities
Capital Expenditures-$272K-$1.24M-$1.25M-$3.34M-$12.64M-$1.38M-$821K-$2.32M-$1.18M-$201K-$878K
Acquisitions$0$0$0$0$110K$9K$0$0$0$0$0
Purchases of Investments-$50.97M$0-$51.41M$0-$108.21M-$96.77M-$41.77M-$25.02M$0$0$0
Sales of Investments$87.02M$68.43M$0$50M$109M$87.5M$27M$0$0$0$0
Other Investing Activities$1.56M$68.43M-$51.41M$0$0$9K-$14.77M-$25.02M$0$0$0
Net Cash from Investing$37.34M$67.19M-$52.65M$46.66M-$11.73M-$10.64M-$15.59M-$27.34M-$1.18M-$201K-$878K
Financing Activities
Debt Repaid$65K$291K$265K-$39.38M$205K$50K$168K$135K$50K--
Common Stock Issuance$43.27M$119.76M$70.34M$102.27M$61.18M$68.51M$32.31M$50.48M-$228K$15K$0
Common Stock Repurchases$0-$81K$0$0$0$0$0$0-$620K$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$257K$11.66M$439K$1.3M$374K$626K$1.8M$395K$0$68.76M$10.04M
Net Cash from Financing$43.46M$131.04M$70.51M$142.95M$65.99M$69.08M$33.94M$90.56M-$278K$68.76M$10.04M
Forex Effect$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$28.91M$75.17M-$81.68M$132.25M-$6M$18.13M-$26.38M$22.68M-$24.48M$56.59M$1.97M
Supplementary Data
Operating Cash Flow-$109.71M-$123.06M-$99.54M-$57.36M-$60.25M-$40.31M-$44.73M-$40.54M-$23.03M-$11.97M-$7.19M
Capital Expenditure-$272K-$1.24M-$1.25M-$3.34M-$12.64M-$1.38M-$821K-$2.32M-$1.18M-$201K-$878K
Free Cash Flow-$109.98M-$124.31M-$100.78M-$60.7M-$72.89M-$41.7M-$45.55M-$42.86M-$24.21M-$12.17M-$8.07M
Cash at Beginning$170.55M$95.39M$177.07M$44.82M$50.81M$32.69M$58.59M$35.91M$60.39M$3.8M$1.83M
Cash at End$141.65M$170.55M$95.39M$177.07M$44.82M$50.81M$32.2M$58.59M$35.91M$60.39M$3.8M